This inventor holds 3 USPTO granted patents and 1 published patent application. Top assignee: Genentech, Inc.. Active years: 2020-2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020-2026
Title: Innovations by John Quinn in Cardiovascular Treatment
Introduction
John Quinn is a notable inventor based in South San Francisco, CA. He has made significant contributions to the field of cardiovascular disease treatment. With a total of 3 patents, his work focuses on innovative methods and compositions that aim to improve patient outcomes.
Latest Patents
John Quinn's latest patents include groundbreaking inventions related to cardiovascular disease. One of his key inventions is centered around PCSK9 inhibitors. This invention provides compositions comprising the PCSK9 inhibitors and methods for identifying and using these inhibitors effectively. His work in this area is crucial for advancing treatment options for cardiovascular conditions.
Career Highlights
John Quinn is currently employed at Genentech, Inc., a leading biotechnology company known for its innovative approaches to medicine. His role at Genentech allows him to collaborate with other experts in the field and contribute to the development of new therapies.
Collaborations
Some of John Quinn's notable coworkers include Maureen H Beresini and Daniel J Burdick. Their collaboration fosters a dynamic environment for innovation and research in cardiovascular treatments.
Conclusion
John Quinn's contributions to the field of cardiovascular disease treatment through his patents and work at Genentech highlight his commitment to improving healthcare. His innovative approaches are paving the way for new therapeutic options in this critical area of medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile